Tissue Diagnostics Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 – 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC785

Introduction

Tissue is a cluster or layer of cells which accomplishes particular function and contains necessary genetic and biological information. Tissue samples are used for cancer analysis, where it captures the biological background of the syndrome. It imitates the presence of cancer by inspecting the tissue sample under microscope by a skilled physician also known as pathologist. Histopathology is a study of syndrome in a tissue which can be cured by small surgeries and open biopsy or surgery. The three major types of tissue diagnosis are Immunohistochemistry (IHC), Hematoxylin and Eosin (H&E), and In situ hybridization. Hence, many kinds of cancer can be cured by using these technologies like breast cancer, gastric cancer, lymphoma, prostate cancer and others.

Market Dynamics

Factor driving the growth of tissue diagnostics market includes improving infrastructure for cancer diagnosis, growing healthcare expenditure, rising incidences of cancer, and technological development and advancements in tissue diagnostics. When compared developing countries to developed countries, there is low health issue awareness due to some factors like low literacy rate, economic factors, etc. which adversely affects the growth of this market in developing countries. Technological development, mandate for better and advanced treatment can boost the growth of this market in near future.

Market Classification

The market can be bifurcated on the basis of product, technology, disease, end user, and geography. By product, tissue diagnostics market can be segmented into consumables and instruments. Consumables can be further bifurcated into antibodies, kits, reagents, probes and instruments are further classified into slide-staining systems, scanners, tissue-processing systems, and others. By technology, tissue diagnostics market can be segmented into in special staining situ hybridization, workflow management immunohistochemistry, and digital pathology. By disease, tissue diagnostics market can be segmented into gastric cancer, breast cancer, lymphoma, non-small cell lung cancer, prostate cancer, and other diseases. By end user, tissue diagnostics market can be segmented intohospitals, pharmaceutical companies, research laboratories, contract research organizations, and among other end users. On the basis of geography, the tissue diagnostics market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific.

Report Coverage

Market

Tissue Diagnostics Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Product, Technology, Disease, End User, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

 

Market Participants

Some of the major players involved in tissue diagnostics market include F. Hoffmann-La Roche AG, The Danaher Corporation, Thermo Fisher Scientific, Abbott  Laboratories, Agilent Technologies, Sakura Finetek Japan Co., Ltd., Sienna Cancer Diagnostics, Royal Philips N.V., A. Menarini Diagnostics Ltd., Cell Signaling Technology, Enzo Life Sciences, Inc., Master Diagnostica S.L., and TissueGnostics among others.

Market Segmentation

Market By Product

  • Consumables
    • Antibodies
    • Kits
    • Reagents
    • Probes
  • Instruments
    • Slide-staining Systems
    • Scanners
    • Tissue-processing Systems
    • Others

Market By Technology

  • Immunohistochemistry
  • In Situ Hybridization
  • Digital Pathology and Workflow Management
  • Special Staining

Market By Disease

  • Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Prostate Cancer
  • Non-small Cell Lung Cancer
  • Others

Market By End User

  • Hospitals
  • Pharmaceutical Companies
  • Research Laboratories
  • Contract Research Organizations
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of LATAM
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Related Reports

Hemophilia Market (By Type: Hemophilia A, Hemophilia B, Hemophilia C; By Treatment: On-demand, Prophylaxis; By Therapy: Replacement Therapy, Gene Therapy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Hemophilia market is estimated to hit nearly USD 17 billion by 2026. The hemophilia market islikely to grow with 5.3% CAGR during the forecast years. Market Dynamics The increasing initiatives at the global level to create awareness about hemophilia dr

Angiography Devices Market (By Product: Catheters, Contrast Media, Angiography Systems, Balloons, Vascular Closure Devices, Angiography Accessories; By Technology: MRA, CT, X-Ray; By Procedure: Endovascular, Coronary, Neurovascular; By Application: Therapeutic, Diagnostic) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global angiography devices Market is projected to worth $16.1 Billion by 2026 and the market is projected to showcase 6.3% CAGR during the forecast period. The angiography devices market is driven by the continuous development in imaging technology for various applications in the healthcare industry. Mar

Diagnostic Ultrasound Market (By Technology: 2D, 3D and 4D, Doppler; By Portability: Trolley, Compact/Handheld; By Application: General Imaging, Cardiology, OB/GYN, Others; By End-user: Hospitals, Maternity Centres, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Diagnostic ultrasound is an ultrasound application based method. Diagnostic ultrasound technique is used to create an image of structures of internal body such as muscles, blood vessels, tendons, joints and other internal organs. Its aim is to exclude pathology or find a source of a disease. Diagnostic ultrasound is also used for examining pregnant women. The report provides analysis of global

Breast Implants Market (By Product: Silicone Implant, Saline Implant; By Shape: Round, Anatomical; By Application: Breast Augmentation, Breast Reconstruction; By Texture: Smooth, Textured; By End Use: Hospitals, Clinics, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Breast implants are medical devices that are used to enlarge the size of breasts either for cosmetic applications or rebuilding purpose. Breast expansion, generally called as breast enlargement, is a popular surgical method that enhances the shape and size of the breast. This method includes the use of breast implants in order to improve the size of the breasts. In clinical terms, breast expan

Urology Devices Market (By Product: Dialysis, Laser & Lithotripsy, Robotic Systems, Endoscopes, Endovision System & Peripheral Instruments, Urodynamic Systems, Stents, Urology Catheters, Urology Guidewires, Urodynamic Systems, Drainage Bags, Others; By End-user: Dialysis Centers, Hospitals, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global urology devices Market is projected worth US$57.4 billion by 2026 and the market is projected to showcase 6.9% CAGR during the forecast period. The urology devices market is driven by the easy availability of urology devices and high occurrence of urology disorder associated with the urinary tract system (UTS) across the globe.

Pet Cancer Therapeutics Market (By Medicine Type: Vaccines, Chemotherapy Drugs; By Species: Dogs, Cats; By Cancer Type: Melanoma, Squamous Cell Cancer, Mast Cell Cancer, Mammary, Lymphoma) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global pet cancer therapeutics Market is projected worth US$345.2 million by 2026 and the market is projected to showcase 10.6% CAGR during the forecast period. The pet cancer therapeutics market is driven by the rapid adoption of innovative pet care medicines. Market Dynamics

Cart Summary